172 related articles for article (PubMed ID: 17891662)
1. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
Appel PW; Oldak R
Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
[TBL] [Abstract][Full Text] [Related]
2. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
Appel PW; Ellison AA; Jansky HK; Oldak R
Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
[TBL] [Abstract][Full Text] [Related]
3. Obstacles in provision of anti-retroviral treatment to drug users in Central and Eastern Europe and Central Asia: a regional overview.
Bobrova N; Sarang A; Stuikyte R; Lezhentsev K
Int J Drug Policy; 2007 Aug; 18(4):313-8. PubMed ID: 17689380
[TBL] [Abstract][Full Text] [Related]
4. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.
Tyndall MW; Kerr T; Zhang R; King E; Montaner JG; Wood E
Drug Alcohol Depend; 2006 Jul; 83(3):193-8. PubMed ID: 16356659
[TBL] [Abstract][Full Text] [Related]
5. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
Cleary M; Hunt GE; Matheson S; Walter G
Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
[TBL] [Abstract][Full Text] [Related]
6. Access to health and social services for IDU: the impact of a medically supervised injection facility.
Small W; Van Borek N; Fairbairn N; Wood E; Kerr T
Drug Alcohol Rev; 2009 Jul; 28(4):341-6. PubMed ID: 19594786
[TBL] [Abstract][Full Text] [Related]
7. Why do drug treatment organizations use contingent staffing arrangements? An analysis of market and social influences.
Lemak CH; Alexander JA; Roy J
J Health Soc Behav; 2003 Jun; 44(2):180-97. PubMed ID: 12866389
[TBL] [Abstract][Full Text] [Related]
8. Effects of drug treatment for heroin sniffers: a protective factor against moving to injection?
Kelley MS; Chitwood DD
Soc Sci Med; 2004 May; 58(10):2083-92. PubMed ID: 15020021
[TBL] [Abstract][Full Text] [Related]
9. The impact of illicit drug market changes on health agency operations in Sydney, Australia.
Gibson A; Day C; Degenhardt L
J Subst Abuse Treat; 2005 Jan; 28(1):35-40. PubMed ID: 15723730
[TBL] [Abstract][Full Text] [Related]
10. Barriers to implementing evidence-based practices in addiction treatment programs: comparing staff reports on Motivational Interviewing, Adolescent Community Reinforcement Approach, Assertive Community Treatment, and Cognitive-behavioral Therapy.
Amodeo M; Lundgren L; Cohen A; Rose D; Chassler D; Beltrame C; D'Ippolito M
Eval Program Plann; 2011 Nov; 34(4):382-9. PubMed ID: 21420171
[TBL] [Abstract][Full Text] [Related]
11. Barriers to accessing generic health and social care services: a qualitative study of injecting drug users.
Neale J; Tompkins C; Sheard L
Health Soc Care Community; 2008 Mar; 16(2):147-54. PubMed ID: 18290980
[TBL] [Abstract][Full Text] [Related]
12. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey.
Healey A; Knapp M; Marsden J; Gossop M; Stewart D
J Health Serv Res Policy; 2003 Jul; 8(3):134-41. PubMed ID: 12869338
[TBL] [Abstract][Full Text] [Related]
13. Street outreach with no streets.
Self B; Peters H
Can Nurse; 2005 Jan; 101(1):20-4. PubMed ID: 15776714
[TBL] [Abstract][Full Text] [Related]
14. Substance abuse treatment in the Commonwealth of Massachusetts: gaps, consequences and solutions.
Brolin MF; Horgan C; Amaro H; Doonan M
Issue Brief (Mass Health Policy Forum); 2005 Nov; (27):1-25. PubMed ID: 16302313
[TBL] [Abstract][Full Text] [Related]
15. Pacific healthcare workers and their treatment interventions for Pacific clients with alcohol and drug issues in New Zealand.
Robinson G; Warren H; Samu K; Wheeler A; Matangi-Karsten H; Agnew F
N Z Med J; 2006 Jan; 119(1228):U1809. PubMed ID: 16462919
[TBL] [Abstract][Full Text] [Related]
16. When the dragon's awake: a needs assessment of people injecting drugs in a small urban centre.
Gustafson DL; Goodyear L; Keough F
Int J Drug Policy; 2008 Jun; 19(3):189-94. PubMed ID: 18472260
[TBL] [Abstract][Full Text] [Related]
17. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users.
Grebely J; Genoway KA; Raffa JD; Dhadwal G; Rajan T; Showler G; Kalousek K; Duncan F; Tyndall MW; Fraser C; Conway B; Fischer B
Drug Alcohol Depend; 2008 Jan; 93(1-2):141-7. PubMed ID: 17997050
[TBL] [Abstract][Full Text] [Related]
18. Alcohol use reduction program in methadone maintained individuals with hepatitis C virus infection.
Nyamathi A; de Castro V; McNeese-Smith D; Nyamathi K; Shoptaw S; Marfisee M; Khalilifard F; Cohen A
J Addict Dis; 2008; 27(4):27-33. PubMed ID: 19042588
[TBL] [Abstract][Full Text] [Related]
19. Toward a client-centered understanding of drug treatment.
McGowan K; Sorge R
Health PAC Bull; 1993; 23(3):4-8, 11-5. PubMed ID: 10171778
[TBL] [Abstract][Full Text] [Related]
20. Supervisor ideology and organizational response: HIV/AIDS prevention in outpatient substance abuse treatment units.
Clapp JD; Burke AC
Adm Soc Work; 1997; 21(1):49-64. PubMed ID: 10166759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
